Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Product Launch

Glenmark Pharmaceuticals Product Launch

Glenmark Pharmaceuticals launched Adapalene Gel USP, 0.1% (OTC) in new pump packs in the USA, expanding its dermatology portfolio.

Source

NSE filing, NSE: GLENMARK. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Glenmark Pharmaceuticals Ltd: key numbers

Share price
₹2,300.00
Market cap
₹64,912 Cr
Revenue (annual)
₹16,983 Cr
Net profit (annual)
₹1,362 Cr
P/E (TTM)
36.1×Sector 46.1×
Promoter holding
46.65%+0.00% QoQ
FII holding
21.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Glenmark Pharmaceuticals Ltd

All →
08:50 IST BSE
Product Launch

Glenmark Pharmaceuticals Product Launch

Glenmark Pharmaceuticals launched RYALTRIS® nasal spray in Brazil to treat moderate to severe allergic rhinitis, expanding its global respiratory product footprint in Latin America.

Other product launch announcements

All →